Improving prediction of ventricular arrhythmia
Research type
Research Study
Full title
Improving prediction of ventricular arrhythmia in patients with impaired left ventricular function
IRAS ID
89205
Contact name
John Chambers
Contact email
Sponsor organisation
Imperial College Healthcare NHS Trust
Research summary
Summary of Results
We recruited people impaired LV function, a major risk factor for ventricular arrhythmia to the study, from three hospitals in West London. As described in the science proposal, we carried out genome-wide association and epigenome-wide association using DNA from whole blood to investigate the association of common genetic variants and DNA methylation with risk of ventricular arrhythmia. However, we found there were no markers reaching either genome-wide significance (P<5x10-8) or epigenome-wide significance (P<1x10-7). There was also no evidence for an excess of association in genome-wide analyses or studies of DNA sequence variation and methylation at candidate gene.
Our studies do not identify genetic variants or DNA methylation markers that have a strong association with risk of ventricular arrhythmia. The results suggest that common genetic variants and DNA methylation are unlikely to provide clinically relevant risk stratification in risk of ventricular arrhythmia.REC name
Wales REC 4
REC reference
12/WA/0371
Date of REC Opinion
21 Dec 2012
REC opinion
Further Information Favourable Opinion